Young Women Less Likely Than Men to Start Meds After AMI

This article originally appeared here.
Share this content:
Young Women Less Likely Than Men to Start Meds After AMI
Young Women Less Likely Than Men to Start Meds After AMI

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- After acute myocardial infarction (AMI), younger women are less likely than younger men to initiate prescribed medications, according to a study published online Oct. 13 in Circulation: Cardiovascular Quality and Outcomes.

Kate Smolina, Ph.D., from the University of British Columbia, and colleagues analyzed linked administrative data sets (health care, prescription drugs, sociodemographic, and mortality information) in British Columbia to identify individuals who were admitted to the hospital for AMI (2007 to 2009) and survived for one year after discharge.

The researchers found that more than two-thirds of AMI survivors initiated treatment on all appropriate medications, given their contraindications, within two months of discharge. Appropriate treatment was significantly more likely to be initiated by younger men than younger women (adjusted odds ratio, 1.38). Only one-third of all AMI survivors filled all appropriate prescriptions for at least 80 percent of the first year after discharge. There was no significant difference in therapy adherence between women and men.

"Overall, the majority of AMI survivors either discontinue treatment or do not refill their prescriptions consistently, suggesting that further improvements in post-AMI therapy management are necessary," write the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »